Anuroop Packaging Limited Overview
Anuroop Packaging Limited is a family-controlled Indian micro-cap that has made corrugated boxes, sheets, liners and kraft rolls since 1995 at a single semi-automatic plant in Wada, in Maharashtra's Palghar district, serving pharmaceutical, stationery, toys, apparel, water-treatment and FMCG customers in the Mumbai–Thane industrial belt. Since FY2018 it has also traded turpentine and dipentene ("gum"). It listed on the BSE SME platform in November 2019 through a INR 2.64 Cr IPO and later raised equity through a rights issue (2021) and a preferential issue (2024). Consolidated revenue peaked at INR 27.85 Cr in FY2024 and fell to INR 15.66 Cr in FY2026. Profitability is driven largely by a wholly owned subsidiary, Sara Solutions, whose business is thinly disclosed. In September 2026 shareholders approved selling the Wada factory undertaking, and the company is entering a strategic transition. At about INR 9 Cr market value, it trades near a quarter of book value with high working-capital intensity, no dividends and no analyst coverage.
Company's own description
On its website and in its regulatory summaries, the company describes itself as a Maharashtra-based packaging business that began in 1995 as a private limited company and became a public limited company on 2 July 2017. It makes corrugated boxes, liners, sheets and kraft rolls, and also produces boxes to customer specifications. It says it serves buyers ranging from large corporates to small and mid-size firms, using a workforce of skilled and semi-skilled operators. Since 2017 it has added trading in gum (turpentine and dipentene). It calls itself a preferred vendor for corrugated boxes and describes its plant as semi-automatic, with an ambition to fully automate it (company website "About" page; ICICI Direct and Motilal Oswal company summaries). Screener.in's summary of the FY2025 annual report characterises APL as an ISO-certified maker of corrugated packaging paper and boards.
The 2019 SME IPO prospectus placed the business as a corrugated box manufacturer based in Wada, Thane, supplying fixed packaging products (corrugated boxes, sheets, boards) to the pharmaceutical, stationery, metals and water-treatment industries. It also disclosed that the promoters had diversified into a different line of business through a wholly owned subsidiary, Sara Solutions Private Limited. The prospectus flagged that inexperience in that new line was a risk to financial position and profitability (IPO Abridged Prospectus, risk factor 10).
Business model and revenue model
| Revenue stream | Nature | Model | Disclosure status |
|---|---|---|---|
| Manufactured corrugated packaging (boxes, sheets, liners, kraft rolls) | Product, made-to-order B2B | Per-unit or per-tonne pricing, customised to order; transactional purchase orders | Exact share of revenue not publicly disclosed (Screener.in shows a "manufactured corrugated boxes" revenue-share metric from the standalone annual report, behind a paywall) |
| Traded gum (turpentine and dipentene) | Product, trading | Buy-sell trading margin | Share of revenue not publicly disclosed; started FY2017-18 |
| Subsidiary revenue (Sara Solutions) | Not clearly described in public sources; MCA classification "other service activities"; one registry profile lists "technical / professional, scientific and technical" | — | Inferred to be about 75% of FY2025 consolidated revenue (see Section 4) |
| Subscription / licensing | — | — | — |
Value-chain position
In the corrugated value chain (kraft paper mills → corrugated board makers → box converters → brand owners and shippers), Anuroop is a small converter. It buys kraft paper and converts it into corrugated board, boxes and liners at a semi-automatic plant, so it is exposed to kraft paper price swings and has limited pricing power over both mills and large customers. Its trading of gum chemicals is unrelated to packaging and adds commodity-trading exposure.
Customers and end-markets
The IPO-era customer list (ipocentral.in summary of the 2019 prospectus) included Kokuyo Camlin, A.W. Faber-Castell (India), Himalaya Organics, Ion Exchange India, Mattel Toys India and Pepe Jeans London. The website carries a testimonial from Ganga Pharmaceuticals Ltd. End markets are pharmaceuticals, stationery, toys, apparel, water treatment, metals and FMCG (Groww summary). Customer concentration, current top-customer list and order book are not publicly disclosed.
Independent characterisation
Anuroop is effectively two businesses in one listed shell. The first is a sub-scale, labour-intensive corrugated converter at Wada whose standalone revenue fell from INR 13.62 Cr (FY2024) to about INR 4.48 Cr (FY2025). The second is a subsidiary, Sara Solutions, that appears to generate most consolidated revenue and much of its profit, but whose operating model is not described in available public material. Consolidated operating margins of 35–44% (FY2025–Q1 FY2027) are far above what a commodity corrugated converter normally earns (typically high single to low double digits). This suggests the consolidated profit pool is driven by non-packaging activity or by income items not visible in the aggregated data. Investors should treat the "packaging company" label with caution until the subsidiary's activities are clearly disclosed. Shareholders approved selling the Wada factory undertaking on 24 Sep 2026, which, if executed, would remove most of the remaining manufacturing footprint.
Strategy
Stated strategy
The company's published mission emphasises premium quality and customer satisfaction at minimal cost. Its vision is to become the first name customers think of for packaging (company website, paraphrased). The FY2026 annual report, as summarised by Multibagg AI, called FY2026 a challenging operating year and set out priorities of operational efficiency, sustainable growth, optimising operations and strengthening the balance sheet. Expansion-led messaging has been dropped. No investor day has been held, no investor presentation published and no earnings call conducted.
Strategic initiatives (last 24 months)
| Date | Initiative | Detail | Status | Source |
|---|---|---|---|---|
| Aug–Oct 2024 | Preferential equity and warrant raise at INR 40 | 3,90,000 shares allotted (about INR 1.56 Cr) plus 12,35,000 warrants (INR 4.94 Cr potential; 25% upfront, about INR 1.24 Cr) | Shares issued; all warrants forfeited 16 Apr 2026 | Motilal Oswal (BSE); ScanX |
| FY2025–FY2026 | Capex programme (CWIP rising to INR 4.86 Cr) | Purpose not disclosed; historically framed as the move toward full automation | Not commissioned; future uncertain given plant sale | Screener.in; company website |
| 14 Aug 2026 | Loan of up to INR 50 Cr convertible into equity | Reported board approval; lender, pricing, tenor and conversion terms not disclosed. At more than 5x market cap, conversion would hand control to the lender | shareholder approval status not confirmed | Multibagg AI |
| 14 Aug 2026 | Proposed change of company name | New name not disclosed in sources reviewed | — | Multibagg AI |
| 2–24 Sep 2026 | Sale/disposal of Wada factory undertaking (land, building, machinery) | Rationale: labour and logistics challenges; proceeds possibly for debt repayment or growth | Approved by shareholders; buyer and price not disclosed | AGM Notice 2026; Whalesbook; ScanX |
| 2,026 | Auditor transition | A Sachdev & Co. replaces Banka & Banka | Completed | BSE, 25 Sep 2026 |
Analyst reading. Several 2026 actions point toward a strategic repositioning of the listed vehicle rather than continuity as a packaging maker: exiting owned manufacturing, reportedly authorising a convertible loan many times the market cap, proposing a name change and changing auditors. That pattern is common in Indian micro-caps before a reverse merger, a business pivot or a change of control. None of these outcomes is confirmed, and investors should track BSE filings closely.
ESG commitments and cost programmes
The website says the company uses environment-friendly manufacturing and makes fully recyclable, biodegradable boxes. No quantified ESG targets, cost-reduction programmes with targets, or medium-term financial guidance have been published.
Medium-term targets / guidance
None published.
Products & Services
The company publishes a short product list and no technical datasheets. The catalog below is complete as far as public disclosure allows. No brand names, version years or pricing models are published for any product.
Manufactured packaging (parent company, Wada plant)
| Product | Description (paraphrased from company material) | Key specifications / capabilities | Target customer | Launch / latest version | Pricing model | Flagship / named offering |
|---|---|---|---|---|---|---|
| Corrugated boxes | Shipping and transit boxes valued for strength, light weight, recyclability and cost-effectiveness; made in many sizes and shapes and customised to order | Ply count, burst strength, GSM and print options not published; produced on a semi-automatic line | Pharma, stationery, toys, apparel, water treatment, FMCG (customers such as Kokuyo Camlin and Faber-Castell India, per 2019 prospectus) | Since 1995 | Per order / per unit, not disclosed | Customised boxes made to customer specification |
| Corrugated sheets | Flat corrugated board that can be cut and formed; lightweight and strong; used directly in packaging or by downstream converters | Not published | Converters, industrial users | Since 1995 | — | None named |
| Corrugated liners | Linerboard and fluting (corrugating medium) components of corrugated board | Not published | Converters; in-house use | — | — | None named |
| Kraft rolls | Kraft paper or paperboard made from kraft-process chemical pulp, supplied in rolls | Not published; the company appears to resell or convert rather than run a paper mill (no mill disclosed) | Converters, packers | — | — | None named |
| Corrugated boards | Listed in the 2019 prospectus alongside boxes and sheets | Not published | Industrial clients | Pre-2019 | — | None named |
Traded products (parent company)
| Product | Description | Target customer | Start | Pricing model |
|---|---|---|---|---|
| Turpentine (gum) | Traded solvent / chemical intermediate | Chemical, paint, fragrance users (not disclosed) | FY2017-18 | Trading margin, not disclosed |
| Dipentene (gum) | Traded terpene solvent | Same as above (not disclosed) | FY2017-18 | Trading margin, not disclosed |
Subsidiary offerings (Sara Solutions)
| Offering | Description | Disclosure |
|---|---|---|
| Not specified | The subsidiary's products or services are not described in any public source reviewed. MCA classification (NIC 93000) indicates "other service activities"; one registry profile lists technical/professional services | — |
Capacity and production
Installed capacity, production volume and capacity utilisation for corrugated boxes and liners (in tonnes) are reported in the annual reports per Screener.in's extracted-metrics list, but the values are paywalled and the annual report could not be retrieved. They are therefore not publicly disclosed here. The website describes the plant as semi-automatic, and management's stated ambition was to move to a fully automatic plant. That plan is now overtaken by the approved sale of the Wada undertaking.
Financial Narrative
All figures consolidated, INR crore, fiscal years ending 31 March, sourced from Screener.in (C-MOTS data, retrieved 19 Oct 2026) unless stated. Ratios marked "analyst-computed" are derived from those figures. Gross profit is not reported by the aggregators and could not be derived reliably (purchases of traded goods are not separated), so it is marked not disclosed.
Income statement
Notes: Diluted EPS is shown equal to basic because the aggregator does not report it separately. FY2026 EPS is INR 2.76 per Screener.in and INR 2.81 per Multibagg AI. Research360 reports slightly different FY2023 operating expenses (17.45) and operating profit (4.34). Kotak Securities shows FY2025-26 revenue of INR 19.86 Cr, which conflicts with all other sources and appears to be an aggregation error.
Margins and growth (analyst-computed)
Gross margin: not publicly disclosed. Revenue CAGR FY2022–FY2026 (4 years): about 0.8% per year. Screener.in reports 5-year sales CAGR of 2%, 3-year −10%, TTM −21%; 5-year profit CAGR 15%, 3-year 5%, TTM −39%.
Commentary. The five-year record has three phases. Expansion (FY2022–FY2024): revenue nearly doubled from INR 15.17 Cr to INR 27.85 Cr, helped by capacity spending (fixed assets rose from INR 2.79 Cr in FY2021 to INR 11.15 Cr in FY2024) and post-rights-issue liquidity. EBITDA margin widened from about 17% to about 23%. Contraction with margin expansion (FY2025): revenue fell 34%, almost entirely from the parent's standalone collapse (INR 13.6–13.8 Cr → INR 4.48 Cr). Yet operating expenses fell even faster (−47%), lifting EBITDA margin to 37%. A margin jump of this size alongside a revenue collapse is unusual for a converter. It is consistent with the revenue mix shifting toward the subsidiary's higher-margin activity and away from low-margin traded and manufactured goods. Research360's cost breakdown shows raw material consumed falling from INR 10.01 Cr (FY2024) to INR 1.88 Cr (FY2025), while "miscellaneous expenses" stayed at INR 7.6–9.9 Cr. Continued decline (FY2026–Q1 FY2027): revenue fell a further 14.6% and net income 24.5%. Interest costs (INR 1.43 Cr) and depreciation (INR 1.05 Cr) now absorb a large share of EBITDA.
Quarterly trend (last 13 quarters)
Source: Screener.in consolidated quarterly. Q1 FY2027 (Jun 2026) details from Fyers and Business Standard: total income from operations INR 1.96 Cr; operating profit INR 1.13 Cr before other income per Fyers (conflicts with Screener's 0.86, likely a classification difference); other income INR 0.271 Cr; interest INR 0.341 Cr; PBT INR 0.538 Cr; tax INR 0.174 Cr; PAT INR 0.364 Cr. Q1 FY2026 had a negative tax charge (−63.64%), so PAT exceeded PBT. Groww reports Q4 FY2026 EPS of INR 0.16 vs INR 2.02 a year earlier, which conflicts with Screener's INR 0.47 vs INR 2.26; the Groww figures may be standalone.
Seasonality and volatility. Q4 (Jan–Mar) has historically been the largest quarter (FY2024 Q4: INR 14.89 Cr, 53% of the year; FY2025 Q4: INR 8.30 Cr, 45%). That pattern weakened in FY2026, where Q4 was only 31% of the year. Q1 FY2027 revenue of INR 1.96 Cr is the lowest quarterly figure in the 13-quarter series, down 38.75% YoY and 60% QoQ. This is consistent with Wada operations winding down ahead of the sale.
Balance sheet
Net debt FY2025–FY2026 from Multibagg AI / Zerodha (Zerodha also reports INR 14.15 Cr at Sep 2025); cash is implied (borrowings minus net debt). Short/long-term debt split, goodwill and working capital in rupee terms: not publicly disclosed in sources reviewed. Blank cells = not disclosed. Book value per share is analyst-computed (equity ÷ shares outstanding); Screener reports INR 35.4 for FY2026, which matches.
Commentary. The balance sheet grew 65% over FY2022–FY2026 while revenue was flat, so asset productivity fell sharply. Three items stand out. (1) Investments of INR 17.50 Cr (30% of total assets) appeared abruptly in FY2023 (funded that year by unusually large operating cash inflow of INR 18.46 Cr) and have grown each year since. Their nature (financial investments, property, related-party instruments) is not disclosed in the sources reviewed, and this is the single most important diligence item. (2) CWIP of INR 4.86 Cr has been carried for four years without being capitalised. Combined with the approved Wada sale, this raises impairment and write-off questions. (3) Reserves rose INR 6.60 Cr in FY2026 against PAT of only INR 3.05 Cr. Part of the FY2025 increase can be reconciled (PAT 4.04 + share premium on the preferential issue of about 1.17 + warrant upfront money of about 1.24 ≈ 6.45). About INR 3.5 Cr of the FY2026 increase is not explained by available data. Debt was reduced by INR 2.0 Cr in FY2026.
Cash flow
Source: Screener.in. Capex is analyst-derived (CFO − FCF). Multibagg AI reports different net cash flow figures (FY2022 0.52; FY2023 −0.74; FY2024 0.19; FY2025 −0.13), a discrepancy between data vendors.
Commentary. Cumulative FY2022–FY2026 operating cash flow was INR 11.09 Cr against cumulative net income of INR 16.15 Cr, a conversion rate of about 69%. That average flatters the record: it depends entirely on the FY2023 inflow of INR 18.46 Cr. Excluding FY2023, the other four years generated combined operating cash flow of −INR 7.37 Cr against INR 13.51 Cr of reported profit. Earnings have mostly been absorbed by working capital, and the FY2024–FY2025 capex and working-capital build was funded with debt and equity (INR 11.6 Cr of financing inflows). No dividends or buybacks have ever been paid.
Ratios
ROCE, working-capital and day-count metrics from Screener.in; ROE, ROA, ROIC, leverage, coverage and turnover analyst-computed from Screener.in data. Current ratio not publicly disclosed (current asset/liability split unavailable). Screener's own FY2026 ROE is 8.51%, which matches.
Commentary. Returns peaked in FY2024 (ROE 17.2%, ROCE 18.3%) and have since fallen to the high single digits as equity kept growing and earnings shrank. Leverage is moderate on a debt-to-equity basis (0.34x). Interest coverage has, however, slipped below 4x, and the business has repeatedly been unable to fund itself from operations. The most alarming signal is working capital: inventory days above 440 and a cash conversion cycle above 330 days in FY2025–FY2026 are extreme for a corrugated converter, which normally turns inventory within one to two months. Either material inventory is held for the trading or subsidiary activity, or the inventory carrying values need scrutiny. Screener's automated flags note working-capital days rising from 208 to 337 and debtor days from 116 to 147.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship | Activity | Key data | Source |
|---|---|---|---|---|
Anuroop Packaging Limited | Listed parent | Corrugated packaging manufacturing at Wada; gum trading | Standalone revenue per table below | Annual reports; Screener.in |
Sara Solutions Private Limited (shown as "Sara Solutions Limited" on the company website) | Wholly owned subsidiary (per 2019 prospectus) | Not clearly disclosed; MCA NIC code 93000 (other service activities); third-party registry describes it as technical/professional services | Incorporated 19 Nov 2012; registered at Malad West, Mumbai; paid-up capital INR 3.92 Cr (TheCompanyCheck) vs INR 0.945 Cr (IndiaFilings), an unresolved discrepancy; financial statements FY2020–FY2025 posted on company website | IPO Abridged Prospectus 2019; company website; MCA aggregators |
"YAL" | Unclear | The FY2025 subsidiary financials file on the company website is named "YAL_Financials.pdf" although labelled Sara Solutions; may indicate a second entity or a renamed one | — | Company website |
Revenue by Segment and Revenue by Segment (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Consolidated revenue (INR Cr) | 14.06 | 15.17 | 21.79 | 27.85 | 18.33 |
Standalone revenue (INR Cr) | 4.59 | 6.25 | 8.02 | 13.62 | 4.48 |
Implied subsidiary revenue (INR Cr) | 9.47 | 8.92 | 13.77 | 14.23 | 13.85 |
Standalone share of consolidated revenue (%) | 32.6 | 41.2 | 36.8 | 48.9 | 24.4 |
Standalone operating margin (%) | 17.65 | 18.72 | 19.58 | 14.83 | — |
Standalone profit before tax (INR Cr) | 0.57 | 0.89 | 1.40 | 1.62 | — |
Consolidated profit before tax (INR Cr) | 1.99 | 2.95 | 3.67 | 5.08 | 5.75 |
Implied subsidiary profit before tax (INR Cr) | 1.42 | 2.06 | 2.27 | 3.46 | — |
Segment Margins & Growth (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Standalone revenue YoY growth (%) | 36.2 | 28.3 | 69.8 | -67.1 |
Implied subsidiary revenue YoY growth (%) | -5.8 | 54.4 | 3.3 | -2.7 |
Consolidated revenue YoY growth (%) | 7.9 | 43.6 | 27.8 | -34.2 |
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (INR Cr) | 15.17 | 21.79 | 27.85 | 18.33 | 15.66 |
Operating expenses (INR Cr) | 12.62 | 17.30 | 21.49 | 11.47 | 10.11 |
EBITDA before other income (INR Cr) | 2.55 | 4.49 | 6.36 | 6.86 | 5.55 |
Other income (INR Cr) | 1.29 | 0.75 | 0.84 | 1.53 | 1.07 |
EBITDA incl. other income (INR Cr) | 3.84 | 5.24 | 7.20 | 8.39 | 6.62 |
Depreciation (INR Cr) | 0.27 | 0.56 | 0.82 | 1.07 | 1.05 |
Operating income EBIT excl. other income (INR Cr) | 2.28 | 3.93 | 5.54 | 5.79 | 4.50 |
Interest expense (INR Cr) | 0.62 | 1.01 | 1.30 | 1.57 | 1.43 |
Pre-tax income (INR Cr) | 2.95 | 3.67 | 5.08 | 5.75 | 4.14 |
Effective tax rate (%) | 20.34 | 28.07 | 19.69 | 29.57 | 26.09 |
Net income (INR Cr) | 2.34 | 2.64 | 4.08 | 4.04 | 3.05 |
EPS basic (INR) | 2.19 | 2.48 | 3.83 | 3.66 | 2.76 |
EPS diluted (INR) | 2.19 | 2.48 | 3.83 | 3.66 | 2.76 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
EBITDA margin before other income (%) | 16.81 | 20.61 | 22.84 | 37.42 | 35.44 |
Operating (EBIT) margin (%) | 15.03 | 18.04 | 19.89 | 31.59 | 28.74 |
Net margin (%) | 15.43 | 12.12 | 14.65 | 22.04 | 19.48 |
Revenue growth YoY (%) | 7.9 | 43.6 | 27.8 | -34.2 | -14.6 |
Net income growth YoY (%) | 57.0 | 12.8 | 54.5 | -1.0 | -24.5 |
Income Statement and Margin Analysis (%) (Jun2023–Jun2026)
| Metric | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (INR Cr) | 2.25 | 5.43 | 7.53 | 14.89 | 3.19 | 3.33 | 3.50 | 8.30 | 3.20 | 3.08 | 4.47 | 4.91 | 1.96 |
Operating profit (INR Cr) | 0.87 | 1.71 | 2.20 | 2.46 | 0.77 | 1.29 | 1.09 | 3.70 | 0.86 | 1.43 | 1.91 | 1.36 | 0.86 |
Operating margin (%) | 38.67 | 31.49 | 29.22 | 16.52 | 24.14 | 38.74 | 31.14 | 44.58 | 26.88 | 46.43 | 42.73 | 27.70 | 43.88 |
Profit before tax (INR Cr) | 0.62 | 1.29 | 1.74 | 2.06 | 0.42 | 1.15 | 0.76 | 3.41 | 0.44 | 1.10 | 1.71 | 0.89 | 0.54 |
Net profit (INR Cr) | 0.55 | 0.85 | 1.31 | 1.91 | 0.33 | 0.87 | 0.33 | 2.50 | 0.72 | 0.42 | 1.38 | 0.52 | 0.36 |
EPS (INR) | 0.52 | 0.80 | 1.23 | 1.79 | 0.31 | 0.82 | 0.30 | 2.26 | 0.65 | 0.38 | 1.25 | 0.47 | 0.33 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 35.70 | 39.07 | 42.95 | 51.36 | 58.84 |
Net fixed assets (INR Cr) | 6.64 | 8.25 | 11.15 | 10.10 | 9.06 |
Capital work-in-progress (INR Cr) | 0.00 | 2.03 | 2.08 | 4.71 | 4.86 |
Investments (INR Cr) | 0.06 | 12.51 | 13.49 | 15.49 | 17.50 |
Other assets incl. inventory, receivables, cash (INR Cr) | 29.00 | 16.28 | 16.23 | 21.06 | 27.42 |
Total borrowings (INR Cr) | 9.80 | 7.73 | 14.63 | 15.15 | 13.15 |
Other liabilities (INR Cr) | 6.69 | 9.72 | 2.60 | 3.66 | 6.54 |
Equity share capital (INR Cr) | 10.66 | 10.66 | 10.66 | 11.05 | 11.05 |
Reserves (INR Cr) | 8.55 | 10.96 | 15.06 | 21.50 | 28.10 |
Total shareholders' equity (INR Cr) | 19.21 | 21.62 | 25.72 | 32.55 | 39.15 |
Book value per share (INR) | 18.02 | 20.28 | 24.13 | 29.46 | 35.43 |
Key Financials
| Metric | FY2025 | FY2026 |
|---|---|---|
Cash & equivalents (INR Cr) | 0.62 | 0.47 |
Net debt (INR Cr) | 14.53 | 12.68 |
Cash Flow and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (INR Cr) | -1.40 | 18.46 | -1.53 | -5.51 | 1.07 |
Capital expenditure (INR Cr) | 4.12 | 3.20 | 3.77 | 4.29 | 0.15 |
Free cash flow (INR Cr) | -5.52 | 15.26 | -5.30 | -9.80 | 0.92 |
Investing cash flow (INR Cr) | -2.83 | -16.07 | -3.92 | -0.15 | -1.11 |
Financing cash flow (INR Cr) | 2.30 | -3.07 | 5.67 | 5.91 | 0.06 |
Net cash flow (INR Cr) | -1.93 | -0.68 | 0.23 | 0.25 | 0.01 |
Dividends paid (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
CFO / EBITDA (%) | -27 | 423 | 13 | -42 | 34 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on average equity (%) | 14.2 | 12.9 | 17.2 | 13.9 | 8.5 |
ROA on average assets (%) | 7.6 | 7.1 | 9.9 | 8.6 | 5.5 |
ROCE (%) | 14.94 | 16.04 | 18.31 | 16.62 | 11.14 |
ROIC approx., after-tax EBIT / (equity + debt) (%) | 9.8 | 11.5 | 12.7 | 10.8 | 7.9 |
Debt / equity (x) | 0.51 | 0.36 | 0.57 | 0.47 | 0.34 |
Gross debt / EBITDA incl. other income (x) | 2.55 | 1.48 | 2.03 | 1.81 | 1.99 |
Net debt / EBITDA incl. other income (x) | — | — | — | 1.73 | 1.92 |
Interest coverage, EBIT incl. other income / interest (x) | 5.8 | 4.6 | 4.9 | 4.7 | 3.9 |
Asset turnover (x) | 0.49 | 0.58 | 0.68 | 0.39 | 0.28 |
Debtor days | 134.50 | 142.38 | 69.85 | 130.23 | 146.84 |
Inventory days | 225.11 | 148.18 | 84.92 | 501.88 | 445.64 |
Payable days | 101.90 | 128.08 | 39.85 | 228.12 | 258.90 |
Cash conversion cycle (days) | 257.71 | 162.47 | 114.92 | 403.98 | 333.58 |
Working capital days | 275.98 | 70.86 | 94.76 | 191.36 | 336.56 |
Revenue by Region and Region Margins & Growth (%)
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Total reported revenue, India-based operations (INR Cr) | 27.85 | 18.33 | 15.66 |
YoY growth (%) | 27.8 | -34.2 | -14.6 |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Last close | INR 8.50 (19 Oct 2026) | Screener.in |
1-year price change | -36% | Screener.in stock price CAGR |
3-year price CAGR | -22% | Screener.in |
5-year price CAGR | -8% | Screener.in |
All-time high | INR 50.00 (23 Feb 2023) | TradingView |
All-time low | INR 6.83 (19 Mar 2021) | TradingView |
IPO price | INR 13.00 (Nov 2019); stock now 35% below | IPO documents |
52-week high / low | INR 18.20 / INR 8.25 | Screener.in |
Beta | 1.30 (TradingView, date of snapshot not stated) | TradingView |
Share Price & Returns
| Date | Close (INR) | Source |
|---|---|---|
22 Dec 2025 | 12.20 | ICICI Direct |
16 Jan 2026 | 10.35 | Business Standard |
6 Feb 2026 | 10.36 | BusinessToday |
6 Mar 2026 | 12.78 | Research360 |
29 Jun 2026 | 12.62 | Trendlyne |
18 Jul 2026 | 13.82 | Torus Digital |
25 Aug 2026 | 10.56 | Multibagg AI |
1 Oct 2026 | 9.76 | Business Standard |
19 Oct 2026 | 8.50 | Screener.in |
Margin Analysis (%) (FY2020–FY2026)
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|
Promoter holding (%) | 68.81 | 68.94 | 49.94 | 49.94 | 49.94 | 48.18 | 44.46 |
Public holding (%) | 31.19 | 31.06 | 50.06 | 50.05 | 50.06 | 51.82 | 55.53 |
Number of shareholders | 142 | 112 | 170 | 168 | 1,693 | 3,718 | 3,587 |
Balance Sheet
| Metric | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|
Equity share capital (INR Cr) | 0.70 | 7.33 | 7.66 | 7.66 | 10.66 | 10.66 | 10.66 | 11.05 | 11.05 |
Valuation Multiples
| Multiple | Anuroop (19 Oct 2026) | Indian packaging industry | EPL Ltd | Source |
|---|---|---|---|---|
P/E (TTM) | 3.5x | 14.7x–18.6x (Simply Wall St industry average, varying by snapshot date) | 20.4x | Screener.in; Simply Wall St; Fyers |
P/B | 0.24x | — | — | Screener.in |
EV / EBITDA (TTM, incl. other income) | about 3.3x | — | 24.7x (as shown by Fyers) | Analyst-computed: EV INR 22.09 Cr = mcap 9.41 + net debt 12.68; TTM EBITDA about INR 6.69 Cr |
EV / Sales (TTM) | about 1.5x | — | — | Analyst-computed: EV ÷ TTM revenue INR 14.42 Cr |
Dividend yield | 0.00% | — | — | Screener.in |
Analyst Conclusions
Management guidance
None quantitative. Qualitative priorities from the FY2026 annual report: operational efficiency, sustainable growth, operational optimisation and balance-sheet strengthening. Sale proceeds from Wada may fund debt repayment or growth initiatives.
Consensus expectations
None (no coverage). The trailing trajectory is negative. TTM revenue is INR 14.42 Cr (−21% YoY) and TTM net profit INR 2.68 Cr (−39%) as of the June 2026 quarter (Screener.in).
Bull case
-
Asset value exceeds market value. Book equity of INR 39.15 Cr is more than 4x the INR 9.41 Cr market cap. If the Wada land, building and machinery are sold at or above book (fixed assets INR 9.06 Cr plus CWIP INR 4.86 Cr) and the INR 17.50 Cr investments are recoverable, realisable value could far exceed the share price.
-
Deleveraging and recapitalisation. Sale proceeds could largely retire the INR 13.15 Cr of borrowings. A convertible facility of up to INR 50 Cr, if real and well-structured, could fund a new, higher-return business, which the proposed name change hints at.
-
Reported profitability persists. Even in a declining year the group earned INR 3.05 Cr (FY2026) at a 35% EBITDA margin. On a 3.5x P/E, any stabilisation in revenue would support a re-rating toward industry multiples of about 15x.
Bear case
-
The listed entity is losing its operating core. Standalone packaging revenue fell about 67% in FY2025, Q1 FY2027 revenue (INR 1.96 Cr) is the lowest on record, and the only plant is being sold. What remains is a subsidiary whose business is not publicly described.
-
Earnings quality is poor. Operating cash flow has been negative in four of five years excluding the one-off FY2023 inflow. Inventory days above 440, about INR 3.5 Cr of unexplained reserve growth and INR 17.50 Cr of undisclosed investments suggest reported book value and earnings may overstate economic value.
-
Governance and dilution risk. A family-controlled board with a combined Chair/MD, auditor resignation after one year, promoter non-exercise of INR 40 warrants, a corrigendum to the annual report, and a reported convertible loan more than 5x market cap together create real risk of value transfer away from minority shareholders.
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable | Why it matters |
|---|---|---|
| By mid-Nov 2026 | Q2 FY2027 results (trading window closed 1 Oct 2026) | Shows whether revenue continues to fall below INR 2 Cr per quarter |
| H2 FY2027 | Wada sale: buyer identity (related party or not), consideration vs book value, use of proceeds | Determines realisable value and possible impairment |
| H2 FY2027 | Formal filing on the convertible loan: lender, terms, conversion price, shareholder approval | Potential change of control and dilution |
| H2 FY2027 | Name-change resolution and any change in Main Object clause (MOA) | Signals a new business direction |
| FY2027 | Disclosure of Sara Solutions' business and of the nature of INR 17.50 Cr investments | Core earnings-quality question |
| Ongoing | Promoter shareholding changes and pledges | Commitment signal |
| May 2027 | FY2027 audited results under new auditor A Sachdev & Co. | First full-year audit after auditor change; watch for qualifications or emphasis-of-matter paragraphs |
Analyst verdict
Anuroop Packaging Limited is no longer best analysed as a corrugated packaging company. The listed parent's own manufacturing revenue fell from about INR 13.6–13.8 Cr in FY2024 to INR 4.48 Cr in FY2025. Shareholders have now approved the sale of its only plant, which management says has been undermined by labour and logistics problems. The consolidated income statement still shows a profitable business, with FY2026 net income of INR 3.05 Cr and an EBITDA margin above 35%. Those profits come mostly from a wholly owned subsidiary, Sara Solutions, whose activities have never been clearly explained to public shareholders. They also come with cash conversion that is weak in most years, inventory days of 446–502 and a cash conversion cycle of 334–404 days.
The valuation, at 0.24x book and 3.5x earnings, is optically cheap. It is cheap for identifiable reasons. Thirty percent of assets sit in undisclosed investments, CWIP has gone uncapitalised for four years, reserves grew INR 3.5 Cr more than profit in FY2026 without explanation, and governance is concentrated in one family. The 2026 sequence of events is the clearest signal: warrant forfeiture by the promoter, auditor resignation, a reported up-to-INR 50 Cr convertible loan, a proposed name change and the sale of the operating plant. Together they suggest the listed vehicle is being prepared for a different purpose. That could unlock value through a credible new business or a clean asset sale. It could equally dilute or sideline minority holders.
On the evidence available, this is a special-situation, event-driven micro-cap rather than an investable packaging franchise. Until those are disclosed in primary filings, the risk-reward is unattractive for institutional capital, and the appropriate stance is Avoid / Monitor, revisiting after the Q2 FY2027 results and any formal disclosure of the loan and asset-sale terms.
Source List
| # | Source | Used for |
|---|---|---|
| 1 | Screener.in — Anuroop Packaging Ltd, consolidated and standalone (C-MOTS data), retrieved 19 Oct 2026 | Financials FY2018–FY2026, quarterly results, ratios, shareholding, announcements |
| 2 | BSE filings (indexed excerpts): board outcomes 2022–2026; AGM notices 2024–2026; scrutiniser reports; Annual Report FY2025-26 notice pages | Corporate actions, addresses, governance, AGM resolutions |
| 3 | Gretex Corporate Services — Anuroop Packaging IPO Prospectus and Abridged Prospectus (2019) | History, IPO terms, subsidiary, risk factors |
| 4 | Company website anurooppackaging.com (Home, About, Committees, Subsidiary pages) | Products, management bios, committees, subsidiary financials list |
| 5 | Simply Wall St (S&P Global Market Intelligence data) | Listing details, top shareholders, valuation vs industry, analyst coverage |
| 6 | Business Standard / Capital Market Live News | Quarterly results Jun 2025, Dec 2025, Jun 2026; shareholding categories; share prices |
| 7 | Multibagg AI (Sep 2026 articles) | FY2026 summary, 14 Aug 2026 board actions, net debt, AGM timetable |
| 8 | ScanX; Whalesbook; Value Research | Warrant forfeiture, Wada sale approval and voting results |
| 9 | Research360; Torus Digital; Zerodha; Groww; Fyers; Kotak Securities; ICICI Direct; TradingView; BusinessToday; 5paisa; Trendlyne; MarketsMojo | Cost breakdown, standalone figures, net debt, price history, peers |
| 10 | Chittorgarh; Zerodha TradingQnA; Motilal Oswal (BSE notices) | Rights issue 2021 and preferential issue 2024 details |
| 11 | Zauba Corp; Tracxn; IndiaFilings; TheCompanyCheck (MCA data) | Director DINs and dates; Sara Solutions registry data |
| 12 | ipocentral.in | IPO-era customer list and promoter names |
| 13 | Ken Research; IMARC Group; Mobility Foresights | Indian paper packaging and kraft paper market size |
| 14 | PrintWeek India; Equitymaster; OkCredit; BoldData; Climate Pledge | Competitor data and industry structure |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | DIN | On board since | Background / education | Source |
|---|---|---|---|---|---|
Akash Amarnath Sharma | Chairman & Managing Director (promoter) | 06,389,102 | Director since 3 Jan 2015; MD since 6 Jul 2018 | B.Com, Mumbai University. Per company website, started in business young, dealt in luxury cars, then bought the then 20-year-old Anuroop business; credited with doubling turnover within two years and converting the plant to semi-automatic | Company website; Zauba; BSE filings |
Shweta Akash Sharma | Non-Executive Director (promoter group) | 06,829,309 | 3 Jan 2015 | Postgraduate (Mumbai University) and MBA; previously ran a fashion-design business for four years; responsible for marketing strategy and CRM. Wife of the MD; sister-in-law of the CFO. Holds 3,25,000 shares; re-appointed by rotation at the 2024 and 2025 AGMs | Company website; AGM Notice 2026; BSE AGM outcomes 2024–25 |
Harsh Ashok Dharod | Non-Executive Independent Director; Chair of Audit and NRC committees | — | — | Advocate; more than a decade of experience in accounting, statutory and internal audit, GST and income-tax matters | Company website |
Jash Dipak Vyas | Non-Executive Independent Director | — | Appointed by special resolution at 29th AGM, 9 Sep 2024 | Risk advisory, internal audit and corporate strategy; in the Founder's Office at a health-claims start-up; formerly CEO of Altairis Advisors and consultant at Tour De Force Consultants | Company website; AGM outcome 2024 |
Satish Prahlad Sharma | Director (per MCA registry, appointed 13 Jan 2020) | 08,664,726 | 13 Jan 2020 | — | Zauba Corp |
“—” = not publicly disclosed.
Executive Leadership Team
| Name | Title | Since | Notes | Source |
|---|---|---|---|---|
Akash Amarnath Sharma | Managing Director | 6 Jul 2018 | Also chairs board and AGMs | BSE filings |
Akshay Amarnath Sharma | Chief Financial Officer | 6 Jul 2018 | Brother of the MD; briefly additional director (16 Jun – 3 Nov 2018); holds 6,14,000 shares (5.56%) | Zauba; Simply Wall St |
Pooja Ketan Shah | Company Secretary & Compliance Officer | — | ICSI membership A46746; signed the 2026 AGM notice | AGM Notice 2026 |
“—” = not publicly disclosed.
Directors' Remuneration
| Attribute | Detail |
|---|---|
Board size | 4 per company website (Akash Sharma, Shweta Sharma, Harsh Dharod, Jash Vyas); MCA records additionally list Satish Prahlad Sharma |
Independence | 2 of 4 independent (50%) on the website board list |
Chair / CEO separation | No. The MD is also Chairman, and the only other non-independent director is his spouse |
Women on board | 1 (Shweta Sharma) |
Audit Committee | Harsh Dharod (Chair, ID), Jash Vyas (ID), Shweta Sharma (NED) |
Nomination & Remuneration Committee | Harsh Dharod (Chair, ID), Jash Vyas (ID), Shweta Sharma (NED) |
Stakeholders Relationship Committee | Shweta Sharma (Chair, NED), Jash Vyas (ID), Harsh Dharod (ID) |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
9 Sep 2024 | Jash Vyas appointed Independent Director; MD remuneration revised | 29th AGM |
14 Aug 2026 | Statutory auditor Banka & Banka resigned, citing pre-occupation with other assignments after completing one financial year | AGM Notice 2026 |
2 Sep 2026 / 24 Sep 2026 | A Sachdev & Co. proposed by board on Audit Committee recommendation and approved by members for five years | BSE disclosure 25 Sep 2026 |
Major Shareholders
| Holder category | Sep 2026 (%) | Source |
|---|---|---|
Promoters & promoter group | 44.46 | Screener.in |
Public | 55.52 | Screener.in |
of which non-institutional investors (bodies corporate etc.) | 7.83 (Jun 2026) | Business Standard |
FIIs / FPIs | 0.00 | Business Standard |
Mutual funds | 0.00 | Business Standard |
Insurance / financial institutions | 0.00 | Business Standard |
Number of shareholders | 3,480 | Screener.in |
Major Shareholders by Rank
| Rank | Holder | Shares | Stake (%) | Relationship |
|---|---|---|---|---|
| 1 | Akash Sharma | 4,589,450 | 41.50 | Promoter, CMD |
| 2 | Akshay Sharma | 614,000 | 5.56 | CFO; brother of CMD |
| 3 | Dilip Chheda | 412,913 | 3.74 | Public |
| 4 | Shweta Sharma | 325,000 | 2.94 | Promoter group, NED |
| 5 | Ritesh Agarwal | 192,000 | 1.74 | Public |
| 6 | Bharat Sharma | 188,250 | 1.70 | Relationship not disclosed |
| 7 | Vijay Poddar | 185,000 | 1.67 | Public |
| 8 | Nayna Chheda | 160,000 | 1.45 | Public |
| 9 | Ranvir Singh | 154,000 | 1.39 | Public |
| 10 | Tushar Pandya | 135,000 | 1.22 | Public |
| 11 | Tej Shah | 125,000 | 1.13 | Public |
| 12 | Srividya N. | 114,524 | 1.04 | Public |
| 13 | Anagh Sharma | 110,000 | 1.00 | Relationship not disclosed |
Competitive Landscape
Key Competitors
| # | Competitor | Segment overlap | Scale / data point | Relative positioning | Source |
|---|---|---|---|---|---|
| 1 | Horizon Packs & Securipax Packaging (JK Paper group) | Corrugated boxes (national) | Combined FY2022 revenue INR 832 Cr; acquired by JK Paper (85%) for about INR 590 Cr | Integrated with India's largest paper maker; more than 50x Anuroop's peak revenue | PrintWeek India |
| 2 | TCPL Packaging Ltd | Paperboard / cartons | — | Large organised player | Ken Research; BoldData |
| 3 | Parksons Packaging Ltd | Cartons / packaging | — | Large organised player | Ken Research |
| 4 | Oji India Packaging Pvt Ltd | Corrugated | — | Multinational corrugated player | Ken Research |
| 5 | ITC Ltd (Paperboards & Packaging) | Paperboard / packaging | — | Integrated conglomerate | Ken Research |
| 6 | Box and Board India | Corrugated (South India) | — | Integrated corrugated solutions | Climate Pledge profile |
| 7 | Kahan Packaging Ltd (BSE 543979) | Packaging (micro-cap) | Market cap about INR 19.9 Cr; P/BV 2.27x | Closest listed micro-cap peer used by Simply Wall St | Equitymaster; Simply Wall St |
| 8 | GKP Printing & Packaging | Corrugated / printing (micro-cap) | — | Peer per Zerodha | Zerodha |
| 9 | Boss Packaging Solutions | Packaging (micro-cap) | — | Peer per Zerodha | Zerodha |
| 10 | Sati Poly Plast, Sabar Flex India, SPP Polymer, Panther Industrial Products | Flexible / plastic packaging (adjacent) | — | Peers per Zerodha classification | Zerodha |
| 11 | Rajeshwari Cans, Raj Packaging, Yashraj Containeurs, Vinayak Polycon, Kuwer Industries | Containers / packaging (adjacent) | — | Peers per Business Standard classification | Business Standard |
| 12 | Unorganised local converters (Bhiwandi–Wada belt) | Corrugated boxes | Not quantifiable | Main day-to-day price competition | Analyst assessment |
Peer Comparison FY2026
| Metric | Anuroop Packaging | EPL Ltd (broad packaging benchmark) | Horizon + Securipax (JK Paper) | Kahan Packaging |
|---|---|---|---|---|
Revenue | INR 15.66 Cr (FY2026) | — | INR 832 Cr (FY2022) | — |
Revenue growth | −14.6% (FY2026) | — | — | — |
Net profit | INR 3.05 Cr (FY2026) | INR 389 Cr annual PAT | — | — |
Net margin | 19.5% | — | — | — |
Market cap | INR 9.41 Cr | INR 7,907 Cr | Unlisted (within JK Paper) | about INR 19.9 Cr |
P/E | 3.5x | 20.4x | — | — |



